Camilia (Laboratoires Boiron)


Welcome to the PulseAid listing for the Camilia drug offered from Laboratoires Boiron. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Laboratoires Boiron
NON-PROPRIETARY NAME: MATRICARIA RECUTITA, RHUBARB, PHYTOLACCA AMERICANA ROOT
SUBSTANCE NAME: MATRICARIA RECUTITA; RHUBARB; PHYTOLACCA AMERICANA ROOT
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2010-12-01
END MARKETING DATE: 0000-00-00


Camilia HUMAN OTC DRUG Details:

Item DescriptionCamilia from Laboratoires Boiron
LABELER NAME: Laboratoires Boiron
DEA SCHEDULE:
ACTIVE STRENGTH: 9; 5; 5([hp_C]/1; [hp_C]/1; [hp_C]/1)
START MARKETING DATE: 2010-12-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0220-9054_58a2c5cf-0702-4ba3-825f-d1d9f7e5bc60
PRODUCT NDC: 0220-9054
APPLICATION NUMBER:

Other MATRICARIA RECUTITA; RHUBARB; PHYTOLACCA AMERICANA ROOT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Laboratoires BoironCamilia